Table 4

Characteristics of participants with PDPS with faster and slower onset of symptoms

CharacteristicsFast onset
(≤10 min)
Slow onset
(>10 min)
P valueES
Participants, n (%)14 (32)30 (68)n/an/a
Female, n (%)8 (57)22 (73)0.316Phi=0.16
Age (years)21.5 (IQR 7.0)22.0 (IQR 6.3)0.577r=0.08
BMI (kg/m2)24.0 (IQR 3.0)24.0 (IQR 5.9)0.821r=0.03
Sport participation (h/week)3.1 (SD±2.1, R 6.0)3.0 (SD±2.0, R 7.0)0.934d=0.03
Tegner Score (0–10)4.0 (IQR 2.3)3.0 (IQR 4.0)0.096r=0.25
VAS-W (0–10)7.0 (IQR 2.0)5.0 (IQR 3.0)<0.001r=0.50
Bilateral PFP, n (%)10 (71)24 (80)0.701Phi=0.10
Symptom duration (months)42.0 (IQR 87.0)40.0 (IQR 48.0)0.696r=0.06
AKPS (0–100)68.0 (IQR 10.0)74.0 (IQR 16.3)0.109r=0.24
TSK (17–68)32.5 (IQR 8.0)32.5 (IQR 10.5)0.940r=0.01
VAS-W sitting (0–10)6.0 (IQR 2.0)5.0 (IQR 4.0)0.038r=0.31
  • Data are presented as numbers (percentages), mean (±SD and range (R)) or median (IQR 25%–75%).

  • AKPS, Anterior Knee Pain Scale; BMI, body mass index; ES, effect size; h/week, hours per week; n, number; n/a, not applicable; PFP, patellofemoral pain; TSK, Tampa Scale for Kinesiophobia; VAS-W, Visual Analogue Scale for Worst pain.